Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2016, Vol. 12 ›› Issue (01): 100 -103. doi: 10.3877/cma.j.issn.1673-5250.2016.01.019

Special Issue:

Review

Diagnostic and treatment progress of neonatal congenital hyperinsulinism

Lin Yang1, Xiaoyan Yang1(), Jing Shi1, Ying Xiong1   

  1. 1. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2015-11-16 Revised:2016-01-22 Published:2016-02-01
  • Corresponding author: Xiaoyan Yang
  • About author:
    Corresponding author: Yang Xiaoyan, Email:

Congenital hyperinsulinism (CHI) is a complex heterogeneous syndrome caused by gene mutations which lead to abnormal secretion of insulin from pancreatic β-cells. The clinical manifestations of neonatal CHI are not typical, and the brain damage is severe. Early recognition, diagnosis and reasonable management of neonatal CHI is very important, but difficult. In recent years, the research progresses of different aspects of CHI, such as molecular genetics, pathology, imaging technology, drug therapy and surgical treatment have been completely changed the clinical management of neonatal CHI. This article reviews recent research progress of the diagnosis and treatment of neonatal CHI.

1
Rahman SA, Nessa A, Hussain K.Molecular mechanisms of congenital hyperinsulinism[J].J Mol Endocrinol, 2015, 54(2):119-129.
2
Arnoux JB, Verkarre V, Saint-Martin C, et al.Congenital hyperinsulinism: current trends in diagnosis and therapy[J].Orphanet J Rare Dis, 2011, 6:63.
3
Üstün NU, Dilli D, Kundak AA, et al.A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism——a case report[J].Fetal Pediatr Pathol, 2013, 32(6):412-417.
4
Arya VB, Mohammed Z, Blankenstein O, et al.Hyperinsulinaemic hypoglycaemia[J].Horm Metab Res, 2014, 46(3):157-170.
5
Petraitien I, Barauskas G, Gulbinas A, et al.Congenital hyperinsulinism[J].Medicina (Kaunas), 2014, 50(3):190-195.
6
Su C, Gong C, Sanger P, et al. Long-term follow-up and mutation analysis of 27 Chinese cases of congenital hyperinsulinism[J]. Horm Res Paediatr, 2014, 81(3):169-176.
7
Roženková K, Güemes M, Shah P, et al.The diagnosis and management of hyperinsulinaemic hypoglycaemia[J].J Clin Res Pediatr Endocrinol, 2015, 7(2):86-97.
8
Yorifuji T, Masue M, Nishibori H.Congenital hyperinsulinism:global and Japanese perspectives[J].Pediatr Int, 2014, 56(4):467-476.
9
James C, Kapoor RR, Ismail D, et al.The genetic basis of congenital hyperinsulinism[J].J Med Genet, 2009, 46(5):289-299.
10
Flanagan SE, Kapoor RR, Hussain K.Genetics of congenital hyperinsulinemic hypoglycemia[J].Semin Pediatr Surg, 2011, 20(1):13-17.
11
Barthlen W. Surgery in congenital hyperinsulinism-tips and tricks not only for surgeons. A practical guide[J].Semin Pediatr Surg, 2011, 20(1):56-59.
12
Arnoux JB, De Lonlay P, Ribeiro MJ, et al.Congenital hyperinsulinism[J].Early Hum Dev, 2010, 86(5):287-294.
13
Dillon PA.Congenital hyperinsulinism[J].Curr Opin Pediatr, 2013, 25(3):357-361.
14
Hussain K, Flanagan SE, Smith VV, et al.An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism[J].Diabetes, 2008, 57(1):259-263.
15
Shah P, Demirbilek H, Hussain K.Persistent hyperinsulinaemic hypoglycaemia in infancy[J].Semin Pediatr Surg, 2014, 23(2):76-82.
16
Yorifuji T.Congenital hyperinsulinism: current status and future perspectives[J].Ann Pediatr Endocrinol Metab, 2014, 19(2):57-68.
17
罗飞宏.先天性高胰岛素血症诊治进展[J].中华儿科杂志,2015,53(6):468-471.
18
Gopal-Kothandapani JS, Hussain K.Congenital hyperinsulinism: role of florine-18L-3, 4 hydroxyphenylalanine positron emission tomography scanning[J].World J Radiol, 2014, 6(6):252-260.
19
Hussain K, Blankenstein O, De Lonlay P, et al.Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management[J].Arch Dis Child, 2007, 92(2):568-570.
20
Arya VB, Senniappan S, Guemes M, et al.Neonatal hypoglycemia[J].Indian J Pediatr, 2014, 81(1):58-65.
21
Edwards TM, Spatz DL.Congenital hyperinsulinism: exclusive human milk and breastfeeding[J].Adv Neonatal Care, 2014, 14(4):262-266.
22
Palladino AA, Stanley CA.A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism[J].Semin Pediatr Surg, 2011, 20(1):32-37.
23
黄佳,陈超.新生儿先天性高胰岛素血症的治疗进展[J].中国实用儿科杂志,2015,30(2):116-120.
24
Yorifuji T, Kawakita R, Hosokawa Y, et al.Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism[J].Clin Endocrinol (Oxf), 2013, 78(6):891-897.
25
Laje P, Halaby L, Adzick NS, et al.Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism[J].Pediatr Diabetes, 2010, 11(2):142-147.
26
Durmaz E, Flanagan SE, Parlak M.A combination of nifedipine and octreotide treatment in a hyperinsulinemic hypoglycemic infant[J].J Clin Res Pediatr Endocrinol, 2014, 6(2):119-121.
27
Le Quan Sang KH, Arnoux JB, Mamoune A, et al.Successful treatment of congenital hyperinsulinism with long-acting release octreotide[J].Eur J Endocrinol, 2012, 166(2):333-339.
28
Senniappan S, Alexandrescu S, Tatevian N, et al.Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia[J].N Engl J Med, 2014, 370(12):1131-1137.
29
Calabria AC, Li C, Gallagher PR, et al.GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K channel[J].Diabetes, 2012, 61(10):2585-2591.
30
Martin GM, Chen PC, Devaraneni P, et al.Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels[J].Front Physiol, 2013, 4:386.
31
Yan FF, Casey J, Shyng SL.Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex[J].J Biol Chem, 2006, 281(44):33403-33413.
32
Chen PC, Olson EM, Zhou Q, et al.Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism[J]. J Biol Chem, 2013, 288(29):20942-20954.
[1] Hongbin Wang, Hongxia Zhang, Wen He, Lijuan Du, Linggang Cheng, Yukang Zhang, Meng Zhang. Ultrasound and contrast-enhanced ultrasound features of low-grade appendiceal mucinous tumor and appendiceal mucinous adenocarcinoma[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(09): 865-871.
[2] Lili Gu, Fan Jiang. Survey and analysis of quality of screening prenatal ultrasound images in Anhui Province[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 671-674.
[3] Linjuan Zhao, Jie Lv, Wensheng Wang, Demao Ma, Tao Hou. Study on the effect of ultrasound guided resection of stellate and cylindrical lactation preserving areas with staining marks[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 634-637.
[4] Fushun Zhong, Lu Yu, Xiaoli Fan, Qifa Ye. Liver transplantation for the treatment of hepatic epithelioid hemangioendothelioma:a case report[J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 293-297.
[5] Ying Xiong, Jinglai Lin, Qi Bai, Jianming Guo, Shuo Wang. How far is AI from clinical application in automated renal cell carcinoma pathological diagnosis?[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 535-540.
[6] of Organ Transplantation of Chinese Medical Association Branch. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 739-748.
[7] Dawen Zheng, Jiandong Wang. Research progress in adjuvant diagnosis of gallbladder cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 769-773.
[8] Qiusheng Wang. Diagnosis and treatment strategy for benign biliary diseases[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 779-782.
[9] Yuhan Yuan, Shengli Yang. Research progress in proteomic analysis of body fluids and tissues in early molecular diagnosis of liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 883-888.
[10] Xuefeng Zhou, Zheyi Dong, Zhe Feng, Guangyan Cai, Xiangmei Chen. Formulation protocol of guidelines for diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 301-305.
[11] Hao Li, Qishuai Chen, Fazhu Fei, Ningwei Zhang, Yuandong Li, Shuochen Wang, Bin Ren. Progress in noninvasive diagnosis of liver fibrosis in chronic liver disease[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 863-867.
[12] Ruiyi Tan. Current advances and developments in diagnosis and treatment of small cell osteosarcoma[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(08): 781-784.
[13] Fangming Liu, Xiuxiu Shi, Chong Tang, Keshi Zhang, Ying Xu, Guishan Wang, Zhenpeng Guan, Xiao Li. Awareness and demand for application of digital therapeutics among orthopedic rehabilitation patients: an analysis of results based on 928 questionnaires[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 654-661.
[14] Ziyang Wang, Hongbin Wang, Xiaojing Liu. Progress in research of serum markers for diagnosis of alpha-fetoprotein negative hepatocellular carcinoma[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 677-681.
[15] Hui Chen, Zupeng Zou, Tiantian Zhou, Yidan Zhang, Haiping Zhang. Progress in research of dermoscopy in differential diagnosis of erythematous dermatosis on the scalp[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 692-698.
Viewed
Full text


Abstract